Highest-materiality recent filing
Veralto Q2 sales up 7.6% to $1.47B, adjusted EPS $1.11; raises full-year guidance
Sales $1,474M (+7.6% YoY); core sales growth 4.2%; Water Quality core growth 5.7%.
Veralto Q1 sales up 6.7% to $1.42B; raises FY adjusted EPS guidance to $4.20-4.28
Sales $1,422M (+6.7% YoY); core sales growth 1.9%; adjusted EPS $1.07, up 13% YoY.
Veralto Q4 sales +3.8% to $1,396M; FY2025 EPS $3.76; raises dividend 18%
Q4 sales $1,396M (+3.8% YoY); core sales +1.6%; net earnings $254M ($1.01 diluted EPS); adjusted EPS $1.04.
Veralto announces $750M share repurchase program with no expiration date
Board approved up to $750M of common stock repurchases on November 25, 2025.
Veralto Q3 sales up 6.9% to $1.4B; raises full-year adjusted EPS guidance to $3.82-$3.85
Sales $1,404M (+6.9% YoY); core sales growth 5.1%.
Veralto Q2 sales up 6.4% to $1.37B, raises FY2025 EPS and core sales guidance
Sales of $1,371M (+6.4% YoY); non-GAAP core sales growth 4.8%.
Veralto Q1 sales up 6.9% to $1.33B, adjusted EPS $0.95; reaffirms FY2025 guidance
Sales $1,332M (+6.9% YoY); core sales growth 7.8%; adjusted operating margin 25.0%.
Veralto Q4 sales $1,345M (+4.4%), adjusted EPS $0.95; FY25 guided $3.60-$3.70
Q4 sales $1,345M (+4.4% YoY); adjusted EPS $0.95; operating cash flow $285M.
Veralto Q3 sales up 4.7% to $1.314B, raises FY EPS guidance to $3.44-$3.48
Sales $1,314M (+4.7% YoY); core sales growth 4.6% non-GAAP; diluted EPS $0.88 GAAP, $0.89 adjusted.
Veralto Q2 sales $1.29B (+2.8% YoY), raises FY adjusted EPS guidance to $3.37-$3.45
Net earnings $203M ($0.81 diluted EPS), adjusted EPS $0.85; both beat prior expectations.
Veralto Q1 2024: Revenue $1.246B, adj. EPS $0.84; raises FY adj. EPS guidance
Sales up 1.8% YoY to $1,246M; core sales growth also 1.8%.
Veralto reports Q4 sales $1.29B (+3.3% YoY); guides FY24 EPS $3.20-$3.30
Q4 net earnings $200M ($0.81 diluted); adjusted EPS $0.87; operating cash flow $263M.
Veralto Q3 sales up 3% to $1.255B; initiates $0.09 dividend; Q4 core sales flat to down
Sales $1,255M (+3% YoY); non-GAAP core sales growth +1%. GAAP EPS $0.83; adjusted EPS $0.75.
Veralto completes spin-off from Danaher, begins trading as VLTO on NYSE
Distribution effective Sept 30, 2023; each Danaher share received 0.3333 Veralto shares as of Sept 13 record date.
Veralto issues $2.1B USD and €500M senior notes; guaranteed by Danaher; proceeds for separation
Issued $700M each of 5.5% notes due 2026, 5.35% notes due 2028, 5.45% notes due 2033.
On July 12, 2024, the Board of Directors (the “Board”) of Veralto Corporation (the “Company”) appointed Vijay P. Sankaran as a Class I member of the Board, effective July 12, 2024.
Linda Filler, Françoise Colpron, Daniel L. Comas, Shyam P. Kambeyanda, William H. King, Walter G. Lohr, Jr., Heath A. Mitts, Cindy L. Wallis-Lage and Thomas L. Williams were appointed to the Board
John T. Schwieters was appointed to the Board
Sameer Ralhan Senior Vice President and Chief Financial Officer
Linda Filler, Françoise Colpron, Daniel L. Comas, Shyam P. Kambeyanda, William H. King, Walter G. Lohr, Jr., Heath A. Mitts, Cindy L. Wallis-Lage and Thomas L. Williams were appointed to the Board
Sylvia Stein Senior Vice President and General Counsel
Linda Filler, Françoise Colpron, Daniel L. Comas, Shyam P. Kambeyanda, William H. King, Walter G. Lohr, Jr., Heath A. Mitts, Cindy L. Wallis-Lage and Thomas L. Williams were appointed to the Board
Lesley Beneteau Senior Vice President, Human Resources
Melissa Aquino Senior Vice President, Water Quality
Mattias Byström Senior Vice President, Product Quality and Innovation
Linda Filler, Françoise Colpron, Daniel L. Comas, Shyam P. Kambeyanda, William H. King, Walter G. Lohr, Jr., Heath A. Mitts, Cindy L. Wallis-Lage and Thomas L. Williams were appointed to the Board
Linda Filler, Françoise Colpron, Daniel L. Comas, Shyam P. Kambeyanda, William H. King, Walter G. Lohr, Jr., Heath A. Mitts, Cindy L. Wallis-Lage and Thomas L. Williams were appointed to the Board
Max materiality 0.90 · Median 0.65 · Most common event earnings